Timber Pharmaceuticals, Inc. (TMBR) has 13 open-market insider trades by 4 insiders since 2020. The most active filer is TardiMed Sciences LLC, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| TardiMed Sciences LLC via Michael Derby | 10% Owner | — | 9 | $3.5M | 2021-09-02 |
| Alan Mendelsohn | EVP & CMO | — | 2 | $9K | 2023-08-20 |
| John Koconis | Chairman | — | 1 | $8K | 2023-08-20 |
| Edward J. Sitar | Dir | — | 1 | $7K | 2023-04-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| John Koconis | President | Buy | $8K | 2021-12-15 |
| Edward J. Sitar | Director | Buy | $7K | 2021-11-23 |
| Alan Mendelsohn | Chief Medical Officer | Buy | $5K | 2021-11-23 |
| TardiMed Sciences LLC | 10% Owner | Sell | $212K | 2021-09-02 |
| TardiMed Sciences LLC | 10% Owner | Sell | $368K | 2021-08-30 |
| TardiMed Sciences LLC | 10% Owner | Sell | $276K |
Companies that share insiders with TMBR, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-08-24 |
| TardiMed Sciences LLC | 10% Owner | Sell | $168K | 2021-08-18 |
| TardiMed Sciences LLC | 10% Owner | Sell | $408K | 2021-06-14 |
| TardiMed Sciences LLC | 10% Owner | Sell | $1.5M | 2021-06-08 |
| TardiMed Sciences LLC | 10% Owner | Sell | $145K | 2021-05-28 |
| Alan Mendelsohn | Chief Medical Officer | Buy | $4K | 2021-03-03 |
| TardiMed Sciences LLC | 10% Owner | Sell | $387K | 2020-09-14 |
| TardiMed Sciences LLC | 10% | Sell | $42K | 2020-09-10 |